Hima Patel
Overview
Explore the profile of Hima Patel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
448
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mosaffa E, Oroujzadeh M, Ramsheh N, Jamshidi E, Patel H, Parekh K, et al.
Int J Biol Macromol
. 2025 Mar;
306(Pt 3):141522.
PMID: 40032126
This study presents the development of eco-friendly, bioinspired Chitosan (CS)/Polyvinyl alcohol (PVA) composite beads cross-linked with layered triple hydroxide (LTH) doped bacterial cellulose microfilament (BCM) Hydrochar as a highly efficient...
2.
Mishra R, Kilroy M, Feroz W, Patel H, Garrett J
Mol Carcinog
. 2024 May;
63(8):1528-1541.
PMID: 38751013
HER3 is mutated in ~2%-10% of cancers depending on the cancer type. We found the HER3-V104L mutation to be activating from patient-derived mutations introduced via lentiviral transduction in HER3KO HER2 ...
3.
Lam G, Patel H, Sharpe H, Li D, Halloran K
Heliyon
. 2024 May;
10(9):e30034.
PMID: 38707432
Background: Metabolic complications post-lung transplant are poorly understood and little is known about how these complications differ between patients with or without cystic fibrosis (pwCF and pwoCF). This study compared...
4.
Marin A, Al Mamun A, Patel H, Akamatsu H, Ye D, Sudhan D, et al.
Cancer Res
. 2023 Jul;
83(18):3145-3158.
PMID: 37404061
Significance: HER2-mutant breast cancers acquire secondary HER2 mutations that drive resistance to HER2 tyrosine kinase inhibitors, which can be overcome by combined inhibition of HER2 and MEK.
5.
Alanazi S, Feroz W, Mishra R, Kilroy M, Patel H, Yuan L, et al.
PLoS One
. 2023 May;
18(5):e0285251.
PMID: 37200287
HER2 is over-expressed in around 15% to 20% of breast cancers. HER3 plays a critical role in HER2 mediated tumorigenesis. Increased HER3 transcription and protein levels occur upon inhibition of...
6.
Patel H, Mishra R, Wier A, Mokhtarpour N, Merino E, Garrett J
Anticancer Drugs
. 2023 Feb;
34(4):519-531.
PMID: 36847042
Reactive oxygen species (ROS) levels are elevated after acquisition of resistance to v-raf murine sarcoma viral oncogene homolog B1 (BRAF) inhibitors including dabrafenib and MEK inhibitors such as trametinib in...
7.
Kilroy M, Park S, Feroz W, Patel H, Mishra R, Alanazi S, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551663
In recent years, the third member of the HER family, kinase impaired HER3, has become a target of interest in cancer as there is accumulating evidence that HER3 plays a...
8.
Patel H, Masten K, Chambers R, Edwards A, Fleszar L, Harvey B, et al.
Am Indian Alsk Native Ment Health Res
. 2022 Jul;
29(2):63-84.
PMID: 35881982
American Indian/Alaska Native (Native) youth face high rates of substance use, teen pregnancy and sexually transmitted infections. In response to the COVID-19 pandemic, Respecting the Circle of Life (RCL), a...
9.
Chambers R, Rosenstock S, Patel H, Zhang Y, Lee A, Melgar L, et al.
Health Educ Res
. 2022 Mar;
37(1):23-35.
PMID: 35260901
American Indian (AI) youth are at increased risk for poor reproductive health outcomes. Parental communication and monitoring are established predictors of sexual risk-taking among adolescents. No program evaluations of sexual...
10.
Richards J, Begay T, Chambers R, Patel H, Mayhew J, Allison-Burbank J, et al.
Front Public Health
. 2022 Feb;
9:790024.
PMID: 35223758
Introduction: Considering the critical role that American Indian and Alaska Native (Native) men play in family and child health, there is an urgent need to collaborate with Native communities in...